Evaluation of planning aims and dose prescription in image-guided adaptive brachytherapy and radiochemotherapy for cervical cancer: Vienna clinical experience in 225 patients from 1998 to 2008

References

• Hanna TP, Shafiq J, Delaney GP, Barton MB. The population benefit of radiotherapy for cervical cancer: Local control and survival estimates for optimally utilized radiotherapy and chemoradiation. Radiother Oncol 2015;114:389–94.
   PubMed Web of Science ®Google Scholar
• Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2004;74: 235–45.
   Web of Science ®Google Scholar
• Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.
   PubMed Web of Science ®Google Scholar
• Palmqvist T, Dybdahl Wanderas A, Langeland Marthinsen AB, Sundset M, Langdal I, Danielsen S, et al. Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer. Acta Oncol 2014;53:1012–8.
   PubMed Web of Science ®Google Scholar
• Haack S, Kallehauge JF, Jespersen SN, Lindegaard JC, Tanderup K, Pedersen EM. Correction of diffusion-weighted magnetic resonance imaging for brachytherapy of locally advanced cervical cancer. Acta Oncol 2014;53:1073–8.
   PubMed Web of Science ®Google Scholar
• Schmid MP, Fidarova E, Pötter R, Petric P, Bauer V, Woehs V et al. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy. Acta Oncol 2013;52:1384–90
   PubMed Web of Science ®Google Scholar
• Hegazy N, Pötter R, Kirisits C, Berger D, Federico M, Sturdza A, et al. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: Impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination. Acta Oncol 2013;52:1345–52.
   PubMed Web of Science ®Google Scholar
• Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83: 148–55.
   PubMed Web of Science ®Google Scholar
• Pötter R, Georg P, Dimopoulos J, Grimm M, Berger D, Nesvacil N. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100: 116–23.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Røhl L, Aagaard T, et al. From point A to the sculpted pear: MR image guidance significantly improves tumor dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010;94:173–80.
   PubMed Web of Science ®Google Scholar
• Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: A single institution experience. Radiother Oncol 2013;107:69–74.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009;75: 56–63.
   PubMed Web of Science ®Google Scholar
• Georg P, Kirisits C, Goldner G, Dörr W, Hammer J, Pötzi R, et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 2009;91:173–80.
   PubMed Web of Science ®Google Scholar
• Georg P, Pötter R, Georg D, Lang S, Dimopoulos JC, Sturdza AE, et al. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys 2012;82:653–7.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Fokdal L, Sturdza AE, Mazeron R, Kirisits C, Lindegaard JC, et al. Dose and volume response for local control in locally advanced cervical cancer treated with EBRT combined with MRI-guided adaptive brachytherapy. Int J Radiat Oncol Biol Phys 2014;90:S91–2.
   Web of Science ®Google Scholar
• Routledge JA, Burns MP, Swindell R, Khoo VS, West CM, Davidson SE, et al. Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys 2003;56: 502–10.
   PubMed Web of Science ®Google Scholar
• Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005;62:901–11.
   PubMed Web of Science ®Google Scholar
• Mazeron R, Castelnau-Marchand P, Dumas I, del Campo ER, Kom LK, Martinetti F, et al. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy. Radiother Oncol 2015; 114:257–63.
   PubMed Web of Science ®Google Scholar
• Schmid MP, Kirisits C, Nesvacil N, Dimopoulos JC, Berger D, Pötter R. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched-pair analysis. Radiother Oncol 2011;100:468–72.
   PubMed Web of Science ®Google Scholar
• Georg P, Lang S, Dimopoulos JC, Dörr W, Sturdza AE, Berger D, et al. Dose volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2011;79:356–62.
   PubMed Web of Science ®Google Scholar
• Liu HW, Malkoske K, Sasaki D, Bews J, Demers A, Nugent Z, et al. The dosimetric quality of brachytherapy implants in patients with small prostate volume depends on the experience of brachytherapy team. Brachytherapy 2010;9:202–7.
   PubMed Web of Science ®Google Scholar
• Beaulieu L, Evans DA, Aubin S, Angyalfi S, Husain S, Kay I, et al. Bypassing the learning curve in permanent seed implants using state-of-the-art technology. Int J Radiat Oncol Biol Phys 2007;67:71–7.
   PubMed Web of Science ®Google Scholar
• Battermann JJ, van Es CA. The learning curve in prostate seed implantation. B Cancer Radiother 2000;(Suppl):119–22.
   Google Scholar
• Le Fur E, Malhaire JP, Baverez D, Delage F, Perrouin-Verbe MA, Schlurmann F, et al. Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy in prostate cancer. Strahlenther Oncol 2012;188:1091–5.
   PubMed Web of Science ®Google Scholar
• Fokdal L, Tanderup K, Hokland SB, Røhl L, Pedersen EM, Nielsen SK, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol 2013;107:63–8
   PubMed Web of Science ®Google Scholar
• Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006;65:624–30.
   PubMed Web of Science ®Google Scholar
• Vale C, Tierney JF, Stewart LA, Brady M, Dinshaw K, Jakobsen A. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802–12.
   PubMed Web of Science ®Google Scholar
• Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol 2014;135: 231–8.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013;51:1510–9.
   Web of Science ®Google Scholar
• Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study. Radiother Oncol 2012;103:305–13.
   PubMed Web of Science ®Google Scholar